Skip to main content
padlock icon - secure page this page is secure

Open Access Use of prostate-specific antigen testing in Medicare beneficiaries: Association with previous evaluation

Download Article:
(HTML 54.1 kb)
(PDF 351.3 kb)

This article is Open Access under the terms of the Creative Commons CC BY-NC licence.

Objective: Determine uptake of prostate-specific antigen (PSA) testing in Medicare beneficiaries according to previous receipt of PSA testing.

Methods: A 5% random sample of men aged 67 years or older without a previous diagnosis of prostate cancer was identified through 2009‐2012 Medicare claims. We measured the annualized frequency of PSA screening among men due for PSA testing, stratified by PSA testing use in the previous 2 years, and clustered by ordering provider.

Results: Throughout the study period, PSA testing use was consistently higher for men with previous screening than for men without previous screening. For men without previous screening, there was a decline in testing that was most pronounced in 2012. Compared with 2009, the corresponding odds ratios were 0.98 [95% confidence interval (CI) (0.96‐1.00)] in 2010, 0.94 [95% CI (0.92‐0.95)] in 2011, and 0.66 [95% CI (0.65‐0.68)] in 2012. In contrast, for men with previous screening, PSA testing frequency was stable from 2009 to 2011, and declined to a lesser extent in 2012 [odds ratio 0.80, 95% CI (0.79‐0.81)].

Conclusion: Receipt of PSA testing is highly dependent on whether an individual was tested in the recent past. In previously unscreened men, the largest decrease occurred in 2012, which may reflect in part the publication of US Preventive Services Task Force guidelines, but there was much less impact among men already being screened.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Medicare; Prostate-specific antigen; clinical practice patterns; mass screening

Document Type: Research Article

Publication date: 01 July 2017

This article was made available online on 18 July 2017 as a Fast Track article with title: "Use of prostate-specific antigen testing in Medicare beneficiaries: Association with previous evaluation".

More about this publication?
  • Family Medicine and Community Health (FMCH) is an open-access journal focusing on subjects that are common and relevant to family medicine/general practice and community health. The journal publishes relevant content across disciplines such as epidemiology, public health, social and preventive medicine, research and evidence based medicine, community health service, patient education and health promotion and health ethics. The journal has a specific focus on the management of chronic illness particularly diabetes, ischaemic heart disease, chronic heart failure, hypertension, bronchial asthma, chronic obstructive airways disease and common mental illness. FMCH is published by Compuscript on behalf of the Chinese General Practice Press

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Membership Information
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more